For the manufacture of a medicament for while reducing the food effect on the bioavailability of fenofibrate, treating hypertriglyceridemia, hyperlipidemia or hypercholesterolemia, the present invention provides a micronized fenofibrate,...
A controlled Release Pharmaceutical composition comprising an effective amount of Pravastatin and Fenofibrate, characterised in that the difference, in abs...
A pharmaceutical composition comprising effective amounts of: pravastatin (a) and / or a pharmaceutically acceptable salt thereof (b) Fenofibrate; and (c) sodium bicarbonate in an amount to confer a pH below 9 when dissolved / dispersed ...
Pharmaceutical ResearchLaw D, Wang W, Schmitt EA, Long MA. 2002. Prediction of poly (ethylene) glycol-drug eutectic compositions using an index based on...
Pharmaceutical ResearchLaw D, Wang W, Schmitt EA, Long MA. 2002. Prediction of poly (ethylene) glycol-drug eutectic compositions using an index based on...
Journal of Pharmaceutical SciencesBuch, P et al." IVIVC for Fenofibrate Immediate Release Tablets Using Solubility and Permeability as In Vitro Predictors for...
Journal of Pharmaceutical SciencesBuch, P et al." IVIVC for Fenofibrate Immediate Release Tablets Using Solubility and Permeability as In Vitro Predictors for...
Pharmaceutical compositions in particulate form or in solid dosage forms comprising a combination of a reduced or low dose of fenofibrate and an HMG CoA reductase inhibitor selected from the group consisting of lovastatin, pravastatin, r...
The invention provides at least a composition for the treatment of elevated levels of triglycerides, comprising a therapeutically effective amount of a fibrate drug, preferably fenofibrate, intimately associated with a surfactant mixture...
